CHARIFSON, Paul S.,CLARK, Michael P.,BANDARAGE, Upul K.,BETHIEL, Randy S.,BOYD, Michael J.,DAVIES, Ioana,DENG, Hongbo,DUFFY, John P.,FARMER, Luc J.,GAO, Huai,GU, Wenxin,KENNEDY, Joseph M.,LEDFORD, Bri
申请号：
MEP201766
公开号：
ME02638B
申请日:
2012.08.01
申请国别(地区):
ME
年份:
2017
代理人:
摘要：
Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula ( I ): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula ( I ) are as described herein. A compound is represented by Structural Formula ( I ) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula ( I ) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.
